RRML - Serum tumor markers for screening and early diagnosis of ovarian cancer
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- February 2024 -
 
Anti-thyroid peroxidase (TPO) ... 18
Romanian Review of Laboratory ... 17
Approaching Risk Management in... 13
Recomandarea comună EFLM-COLA... 13
Identification of shared hub g... 13
Challenges in prophylactic the... 13
Monocyte to high-density lipop... 10
Atellica CH 930 chemistry anal... 8
Understanding the key differen... 8
Setting up an own laboratory p... 7

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 21(4)/2013 DOI:10.2478/rrlm-2013-0046
XML
TXT

Serum tumor markers for screening and early diagnosis of ovarian cancer

Octavian Gabriel J. Olaru, Cătălina Monica C. Pena


Abstract:

Discovery of new biomarkers or panels of biomarkers for early diagnosis of ovarian cancer is one of the great challenges of modern medicine. The use of determination of CA125 (the most commonly used biomarker) was improved by taking into account the dynamic values available in the context of screening. Currently, the highest sensitivity of screening tests performed for early diagnosis of ovarian cancer is 96% and was obtained using a panel of serum biomarkers composed of apolipoprotein A1, transthyretin, transferrin and CA125. This paper presents different types of serum proteins that are currently studied, and should be proposed as new biomarkers for detecting ovarian cancer. Future research needs to be conducted in order to find a new tumor marker panel that is quantitative, reproducible, and fast and has an even higher sensitivity and specificity for the early detection of ovarian cancer.

Keywords: ovarian cancer,early diagnosis,serum biomarkers or serum tumor markers,sensitivity,specificity

 
  PDF Download full text PDF
(128 KB)
     
 
How to cite
Olaru OGJ, Pena CMC. Serum tumor markers for screening and early diagnosis of ovarian cancer. Rev Romana Med Lab. 2013;21(4):465-72. DOI:10.2478/rrlm-2013-0046